WOMO HEALTH

Strategic Information

This page contains confidential acquisition and partnership information. Enter the access code to continue.

Incorrect access code. Contact techmaehealth@gmail.com for access.

This document is confidential and intended solely for authorized parties. Unauthorized distribution is prohibited. © 2026 TechMae LLC.

CONFIDENTIAL · PATENT PENDING · APRIL 2026

Acquiring WOMO Health Means
Owning the Category.

WOMO Health is the first and only personal body intelligence system built exclusively for women's biology. We are not an app. We are a category — and we define it. This document outlines our strategic value, technology assets, and partnership opportunities for qualified acquirers and strategic partners.

ACQUISITION STRATEGIC PARTNERSHIP LICENSING
Start the Conversation View Valuation →

COMPANY SNAPSHOT

The numbers behind the opportunity

15+
INTELLIGENCE TOOLS BUILT & DEPLOYED
Patent pending — first mover
200+
PROPRIETARY MAE AUDIO FILES
Pre-recorded, owned outright
6
HORMONAL BODY PROFILES
No competitor has this architecture
84%
GROSS MARGIN AT SCALE
$0.014/user/month in tech costs
$50B
TOTAL ADDRESSABLE MARKET
Women's health — growing 15%/yr
7 YRS
IN DEVELOPMENT & COMMUNITY
TechMae LLC founded 2019
$99
PRICE CEILING AT FULL SYSTEM
18-month roadmap to full pricing
10
USERS TO BREAK EVEN
Exceptional unit economics

ASSET SUMMARY

What an acquirer actually gets

WOMO is not just a subscription app. It is a technology platform, a proprietary AI system, a voice personality, a data architecture, and a brand — all built around a category that no one else has claimed.

⚖️
Intellectual Property
Patent-pending technology covering proprietary women's health intelligence methods. First mover filing in a category no one else has defined.
  • USPTO patent pending — women's body intelligence system
  • Proprietary Mae AI personality framework
  • 6-body-profile hormonal architecture
  • Cross-tool pattern detection methodology
  • WOMO brand, wordmark, and trade dress
  • 200+ original audio recordings — owned outright
📱
Technology Platform
Production-ready Flutter app for iOS and Android. DeepSeek AI integration. ElevenLabs voice system. AWS infrastructure. All code owned by TechMae LLC.
  • Flutter codebase — iOS + Android, production ready
  • 15+ built and functional intelligence tools
  • DeepSeek AI integration — personalization engine
  • ElevenLabs voice system — Mae personality architecture
  • AWS S3 + CloudFront CDN — audio delivery at scale
  • Assessment engine — 18-question AI personalization flow
  • PayPal/Stripe payment integration
  • Web platform — womo-health.com — live
🧠
Mae — The AI Health Companion
Mae is not a chatbot. Mae is a fully developed AI health companion with a defined personality framework, 200+ pre-recorded responses, and a voice that women trust.
  • Eleanor energy framework — 4 personality pillars
  • 200+ pre-recorded voice files — zero marginal cost to serve
  • ElevenLabs Voice ID — owned and cached
  • Validation-first response architecture
  • Condition-specific intelligence (fibroid, PCOS, endo, etc.)
  • Expandable to Spanish, French, and all ElevenLabs languages
📊
WOMO Intelligence Network
The most valuable long-term asset. Every user interaction builds the largest proprietary dataset on women's biology ever assembled. This data moat compounds with every new user.
  • Hormonal cycle data across 6 body profiles
  • Symptom + condition pattern library
  • Gut-hormone correlation dataset
  • Medication-cycle interaction data
  • Real-time biometric data (heart rate, tongue analysis)
  • Licensable to pharmaceutical, research, and insurance partners
  • Research partnership eligibility — NIH, CDC, HHS

MARKET COMPARABLES

What the market says
this category is worth

Women's health technology has commanded significant valuations. WOMO is the only platform that combines cycle intelligence, biometric scanning, AI voice companion, and medical advocacy in one system.

COMPANY CATEGORY VALUATION / EXIT WHAT THEY HAD WOMO ADVANTAGE
Flo Health Period tracking app $800M valuation Cycle tracking only WOMO adds 14+ tools, AI voice, medical advocacy
Clue (BioWink) Period tracking $30M raised Cycle + basic health WOMO adds biometrics, Mae AI, 6 body profiles
WHOOP Health wearable $3.6B valuation Hardware + data WOMO is phone-first — no $299 hardware required
Maven Clinic Women's virtual care $1.35B valuation Telehealth for women WOMO is AI-native — 84% margin vs. provider costs
Hims & Hers Women's health DTC $1.6B market cap Products + telehealth WOMO adds daily intelligence + medical advocacy
Ovia Health (acq. LabCorp) Fertility + pregnancy Acquired — undisclosed Fertility tracking WOMO covers full women's lifecycle — not just fertility
WOMO Health Women's body intelligence OS Seeking strategic partner All of the above — in one First mover · Patent pending · 84% margin
$50B
Total addressable market — women's health intelligence globally
84%
Gross margin at scale — exceptional for a health platform
$13.8M
Projected annual revenue at 10,000 subscribers + add-ons

* Comparable valuations sourced from public filings, press releases, and Crunchbase. WOMO valuation subject to independent assessment.

THE DATA MOAT

The asset that compounds
with every user

WOMO's most valuable long-term asset is not the app — it's the WOMO Intelligence Network. Every check-in, every symptom log, every heart rate scan builds the largest proprietary dataset on women's biology ever assembled. This is what a strategic acquirer is really buying.

🔄Hormonal Pattern Data
Cross-cycle hormonal patterns across 6 body profiles — including menopause, hysterectomy, and birth control users. No dataset like this exists anywhere.
Value: Pharma R&D, insurance underwriting, clinical research
💊Medication-Hormone Interactions
Real-world data on how GLP-1, birth control, HRT, and psychiatric medications affect women's hormonal patterns — data the clinical system doesn't collect.
Value: FDA submissions, drug development, clinical trials
❤️Biometric + Symptom Correlation
Heart rate variability, tongue analysis, gut health, and pain patterns correlated with cycle phase and hormonal state. Pioneering dataset.
Value: Medical device development, diagnostic AI training
🩺Medical Dismissal Patterns
Documented cases of women being dismissed by doctors — symptom timelines, diagnosis delays, condition patterns. Unprecedented for health equity research.
Value: NIH research, health equity initiatives, policy advocacy
🌿Fibroid + PCOS + Endo Intelligence
Symptom onset patterns, cycle correlations, and treatment timelines for the three most underdiagnosed conditions in women's medicine.
Value: Diagnostic tools, specialist referral algorithms, research
🔗Cross-Tool Pattern Intelligence
The connection between gut health, mental wellness, sleep, and cycle phase — analyzed together. No siloed data. Mae connects every dot.
Value: Holistic health AI training, insurance risk modeling

STRATEGIC FIT

Who benefits most
from acquiring WOMO

Amazon Health
BIG TECH / HEALTH DISTRIBUTION
Amazon is building women's health infrastructure. WOMO's AI intelligence layer + data moat fills the gap between One Medical and consumer health.
Synergy: Prime Health + WOMO = complete women's OS
CVS Health / Aetna
HEALTH PLAN + RETAIL PHARMACY
CVS owns MinuteClinic + Aetna insurance. WOMO as a member benefit reduces claims, improves outcomes, and drives retention for female members.
Synergy: 40M female members + WOMO daily intelligence
Google Health
AI + HEALTH DATA
Google is building health AI and needs women's data. WOMO's proprietary dataset and Mae's AI architecture is exactly what Google Health is missing.
Synergy: Google AI + WOMO data moat = women's health model
UnitedHealth / Optum
LARGEST US HEALTH COMPANY
Optum is the most aggressive digital health acquirer in the market. WOMO's member engagement platform + clinical intelligence fits directly into their stack.
Synergy: 50M+ female members needing health intelligence
Hims & Hers Health
WOMEN'S HEALTH DTC
Hims & Hers is already in women's health products and telehealth. WOMO adds daily intelligence, AI companion, and the medical advocacy layer they don't have.
Synergy: Products + telehealth + WOMO daily intelligence
Johnson & Johnson
CONSUMER HEALTH / MEDTECH
J&J's consumer health division (Kenvue spin-off) needs digital intelligence to go with their women's health product portfolio. WOMO is the OS layer.
Synergy: Consumer health products + WOMO intelligence platform

REVENUE MODEL

Multiple streams. High margins.
Clear growth path.

Monthly Subscription
$25/month base — all 10 core tools
85% margin
Add-on Tools
$9.99/month per specialized tool
85% margin
Mae Report
$50 one-time — AI-generated health PDF
99.9% margin
Ask Mae
$0.99/query — AI health answers
91% margin
Enterprise / Sponsorship
$17-22/woman/month — group licensing
80%+ margin
Data Licensing (roadmap)
Research + pharma partnerships
95%+ margin
5-YEAR REVENUE PROJECTION
2026 — Launch
$30K
2027 — Growth
$294K
2028 — Scale
$948K
2029 — Enterprise
$3.2M
2030 — Full System
$13.8M

DEAL STRUCTURES

How we can work together

We are open to multiple structures depending on your organization's strategic goals. We are not looking for a feature acquisition — we are looking for a partner who sees the category.

OPTION A
Strategic Investment
Investment in TechMae LLC in exchange for equity stake. WOMO remains independently operated with strategic resources and distribution from partner.
  • Equity stake in TechMae LLC
  • WOMO remains independently operated
  • Strategic distribution + resources
  • Board seat available at threshold
  • Option to acquire at future milestone
PREFERRED
OPTION B
Full Acquisition
Complete acquisition of TechMae LLC including all WOMO Health assets, IP, codebase, brand, and team. Founder available to lead product division post-acquisition.
  • All technology assets + codebase
  • Patent + all intellectual property
  • Mae voice system + audio library
  • WOMO Intelligence Network data
  • Brand, domain, and trade dress
  • Founding team retention option
  • Enterprise + government contracts
OPTION C
Technology Licensing
License the WOMO technology stack, Mae AI system, and intelligence methodology for integration into your existing platform or health benefit offering.
  • Technology + API licensing
  • Mae AI personality white-label
  • Integration support included
  • Ongoing development partnership
  • Revenue share on licensed users

THE TEAM

Built by women who refuse
to accept the alternative

P
Pamela Nicole Hibbler
CO-FOUNDER & CEO
M.S. Cybersecurity. 7+ years building technology for women through TechMae LLC. Architect of WOMO's intelligence framework, Mae's personality, and all product strategy. Albany, Georgia.
V
Vanessa Bishop-Moore
CO-FOUNDER & PRESIDENT
Strategic leadership, community partnerships, and organizational development. Co-architect of WOMO's vision and brand positioning. Deep roots in women's advocacy and community health.

START THE CONVERSATION

We built the category.
Let's build the future together.

If you're a strategic acquirer, health system, or investment firm that sees what we see — let's talk. All inquiries are confidential.

Confidential Inquiry

All inquiries are handled directly by Pamela Nicole Hibbler, CEO. Response within 24 hours.

Direct contact: techmaehealth@gmail.com

All communications are strictly confidential